Online citations, reference lists, and bibliographies.

The Eligibility For Local-regional Treatment Of Peritoneal Surface Malignancy.

V. Verwaal, S. Kusamura, D. Baratti, M. Deraco
Published 2008 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
At the Fifth International Workshop on Peritoneal Surface Malignancy, held in Milan, the consensus on technical aspects of cytoreductive surgery (CRS) for peritoneal surface malignancy was obtained through the Delphi process. General conflicting points concerning the eligibility to the local-regional therapy were discussed and voted.
This paper references
10.1097/01.sla.0000133183.15705.71
Incomplete Cytoreduction in 174 Patients With Peritoneal Carcinomatosis From Appendiceal Malignancy
O. Glehen (2004)
10.1016/J.EJSO.2006.03.013
Treatment of synchronous peritoneal carcinomatosis and liver metastases from colorectal cancer.
D. Elias (2006)
Heat penetration in locally applied hyperthermia in the abdomen during intra-operative hyperthermic intraperitoneal chemotherapy.
S. van Ruth (2003)
Recurrent intraabdominal cancer with intestinal obstruction
Averbach Am (1995)
10.1007/s002800051093
Successful management of microscopic residual disease in large bowel cancer
P. Sugarbaker (1999)
10.1002/cncr.20836
Abdominal computed tomography scans in the selection of patients with malignant peritoneal mesothelioma for comprehensive treatment with cytoreductive surgery and perioperative intraperitoneal chemotherapy
T. Yan (2005)
10.1111/J.1525-1438.2006.00580.X
Long‐term survival in advanced ovarian carcinoma following cytoreductive surgery with standard peritonectomy procedures
A. Tentes (2006)
10.1007/s004230050246
Management of peritoneal-surface malignancy: the surgeon’s role
P. Sugarbaker (1999)
10.1177/030089160509100503
Computed Tomographic Characterization of Malignant Peritoneal Mesothelioma
T. Yan (2005)
10.1016/J.EJSO.2005.09.016
Preoperative computed tomography and selection of patients with colorectal peritoneal carcinomatosis for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
E. de Bree (2006)
10.1001/ARCHSURG.141.5.460
Solitary colorectal liver metastasis: resection determines outcome.
T. Aloia (2006)
10.1016/J.EJSO.2006.03.012
Comprehensive management of diffuse malignant peritoneal mesothelioma.
P. Sugarbaker (2006)
10.1200/JCO.2004.10.012
Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: a multi-institutional study.
O. Glehen (2004)
10.1053/CTRV.2001.0232
Rationale and techniques of intra-operative hyperthermic intraperitoneal chemotherapy.
A. Witkamp (2001)
10.1002/bjs.4516
Predicting the survival of patients with peritoneal carcinomatosis of colorectal origin treated by aggressive cytoreduction and hyperthermic intraperitoneal chemotherapy
V. Verwaal (2004)
Abdominal computed tomographic scan in the selection of patients with mucinous peritoneal carcinomatosis for cytoreductive surgery.
P. Jacquet (1995)
10.1002/JSO.20013
Toxicity of cytoreductive surgery and hyperthermic intra-peritoneal chemotherapy.
V. Verwaal (2004)
10.1001/ARCHSURG.138.1.26
Factors predicting survival after intraperitoneal hyperthermic chemotherapy with mitomycin C after cytoreductive surgery for patients with peritoneal carcinomatosis.
P. Shen (2003)
10.1002/bjs.4695
Treatment of peritoneal dissemination from gastric cancer by peritonectomy and chemohyperthermic peritoneal perfusion
Y. Yonemura (2005)



This paper is referenced by
10.1002/wnan.1451
Nanoparticle drug-delivery systems for peritoneal cancers: a case study of the design, characterization and development of the expansile nanoparticle.
Aaron H. Colby (2017)
10.1016/j.cpsurg.2019.100727
Current practices and future steps for hyperthermic intraperitoneal chemotherapy.
A. Fields (2020)
10.1007/s10585-016-9791-0
Adhesion molecules in peritoneal dissemination: function, prognostic relevance and therapeutic options
N. Sluiter (2016)
Cytoreductive surgery and HIPEC for peritoneal metastases combined with curative treatment of colorectal liver metastases
(2016)
10.4251/wjgo.v2.i1.31
Selection of patients and staging of peritoneal surface malignancies.
E. Cotte (2010)
10.1016/j.ejso.2013.02.018
Primary peritoneal serous carcinoma treated by cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy. A multi-institutional study of 36 patients.
N. Bakrin (2013)
10.1016/j.clcc.2015.12.006
Bevacizumab in Addition to Palliative Chemotherapy for Patients With Peritoneal Carcinomatosis of Colorectal Origin: A Nationwide Population-Based Study.
L. Razenberg (2016)
10.1007/978-3-319-99510-6_4
Standardizing of Mesothelioma and Pseudomyxoma Care
Ranyell Spencer Sobreira Batista (2019)
10.3748/wjg.v20.i20.6113
Role of surgery in colorectal cancer liver metastases.
Ö. Akgül (2014)
10.11648/j.ijcocr.20170204.11
Peritoneal Cancer Indexes in Ovarian Carcinomatosis: Correlation Between CT and Intraoperative Results and Survival
Lombardo Galera Maria Sagrario (2017)
10.1016/J.EJSO.2011.03.134
Perioperative fast track program in intraoperative hyperthermic intraperitoneal chemotherapy (HIPEC) after cytoreductive surgery in advanced ovarian cancer
P. C. Campos (2011)
10.1097/PPO.0b013e3181a58d7c
Long-Term Results of Cytoreduction and HIPEC Followed by Systemic Chemotherapy
V. Verwaal (2009)
10.1016/j.ejso.2011.03.134
Perioperative fast track program in intraoperative hyperthermic intraperitoneal chemotherapy (HIPEC) after cytoreductive surgery in advanced ovarian cancer.
P. Cascales Campos (2011)
10.1007/s10585-016-9779-9
Versican and vascular endothelial growth factor expression levels in peritoneal metastases from colorectal cancer are associated with survival after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy
N. Sluiter (2016)
10.1016/j.ejso.2009.07.005
Peritoneal carcinomatosis and liver metastases from colorectal cancer treated with cytoreductive surgery perioperative intraperitoneal chemotherapy and liver resection.
T. Chua (2009)
10.1007/978-981-10-7053-2_7
Diagnostic Laparoscopy for the Evaluation of Peritoneal Metastases
A. Ben-Yaacov (2018)
10.1016/j.ctrv.2012.11.003
Cytoreductive surgery and HIPEC for peritoneal metastases combined with curative treatment of colorectal liver metastases: Systematic review of all literature and meta-analysis of observational studies.
E. D. de Cuba (2013)
10.18632/oncotarget.16480
Peritoneal carcinomatosis: limits of diagnosis and the case for liquid biopsy
J. McMullen (2017)
10.1016/J.CIRENG.2017.05.008
Influence of simultaneous liver and peritoneal resection on postoperative morbi-mortality and survival in patients with colon cancer treated with surgical cytoreduction and intraperitoneal hyperthermic chemotherapy.
Rafael Morales Soriano (2017)
Systemic Treatment for Advanced Colorectal cancer : Bridging the gap between clinical studies and daily practice
L. Razenberg (2017)
10.1186/s12957-020-01837-4
Readmissions after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy—a national population-based study
Paul Dranichnikov (2020)
10.1093/gastro/gov044
Treatment of peritoneal metastases from colorectal cancer
L. März (2015)
10.1007/s13193-016-0539-8
Role of Imaging in Peritoneal Surface Malignancies
S. Krishnamurthy (2016)
10.1007/978-3-319-16205-8
Current Controversies in Cancer Care for the Surgeon.
Katherine A. Morgan (2016)
10.1016/j.ejso.2020.02.011
Peritoneal mesothelioma: PSOGI/EURACAN clinical practice guidelines for diagnosis, treatment and follow-up.
S. Kusamura (2020)
10.1007/978-981-10-7053-2_3
Cytoreductive Surgery for Peritoneal Metastases: Principles and Techniques
Aditi Bhatt (2018)
A proposal of Brazilian Society of Surgical Oncology for standardizing cytoreductive surgery plus hypertermic intraperitoneal chemotherapy procedures in Brazil : pseudomixoma peritonei , appendiceal tumors and malignant peritoneal mesothelioma
P. Batista (2017)
10.1245/s10434-012-2465-5
The Role of Laparoscopy in Peritoneal Surface Malignancies Selected for Hyperthermic Intraperitoneal Chemotherapy (HIPEC)
Antonio Sommariva (2012)
10.2217/fon-2016-0389
Strategies to prevent peritoneal carcinomatosis arising from colorectal cancer.
Maximiliano Gelli (2017)
10.1684/bdc.2010.1063
Hyperthermic intraperitoneal chemotherapy with oxaliplatin and without adjuvant chemotherapy in stage IIIC ovarian cancer.
N. Carrabin (2010)
10.1002/jso.21325
Indications and patient selection for cytoreductive surgery and perioperative intraperitoneal chemotherapy.
S. González-Moreno (2009)
10.1007/978-88-470-5711-1_13
Patient Selection for Treatment
P. Sammartino (2015)
See more
Semantic Scholar Logo Some data provided by SemanticScholar